This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Isaacs JT (1990) Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention. Prostate Suppl 3:1–7.
Garraway WM, Collins GN, Lee RJ (1991) High prevalence of benign prostatic hypertrophy in the community. Lancet 338:469–471.
Glynn RJ, Campion EW, Bouchard GR, Silbert JE (1985) The development of benign prostatic hyperplasia among volunteers in the normative aging study. J Epidemiol 121:78–82.
Chilton CP, Morgan RJ, England HR (1978) A critical evaluation of the results of transurethral resection of the prostate. Brit J Urol 50:542–546.
Abrams PH, Farrar DJ, Turner-Warwick RT (1979) The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol 121:640–642.
Roos N, Wenneburg JE, Fisher ES (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320:1120–1124.
Evans JWH, Singer M, Chapple CR, Macartney N, Coppinger SWV, Milroy EJG (1991) Haemodynamic evidence of per-operative cardiac stress during transurethral prostatectomy: preliminary communication. Br J Urol 67:376–380.
Evans JWH, Singer M, Chapple CR, Macartney N, Coppinger SWV, Milroy EJG (1992) Haemodynamic responses and core temperature changes during transurethral prostatectomy and non-endoscopic general surgical procedures in age matched men. Br Med J 304:666–671.
Lu-Yao G, Barry MJ, Chang CH, Wasson JH, Wennberg JE (1994) Transurethral resection of the prostate among Medicare beneficiaries in the United States: Time trends and outcomes. Urology 44(5):693–699.
Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC (1989) Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 141:243–247.
McConnell J, Barry M, Bruskewitz R. (1994) Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guidelines, No 8. AHCPR Publication 940582. Rockville, MD, Agency for Health Care Policy and Res, Public Health Serv, US Dept of Health Human Serv.
Sigwart U, Puel J, Mirkovitch V, et al. (1987) Intravascular stents to prevent occlusion and rectenosis after transluminal angioplasty. N Engl J Med 316:701–706.
Rousseau H, Puel J, Joffre F, et al. (1987) Self-expanding endovascular prosthesis: an experimental study. Radiology 164:709–714.
Milroy EJG, Chapple CR, Cooper JE, et al. (1988) A new Treatment for urethral strictures. Lancet 1:1424–1427.
Sarramon JP, Joffre F, Rischmann P, et al. (1989) Prosthese endourethrale Wallstent dans les stenoses recidivantes de l’urethre. Ann Urol 23:383–387.
Chapple CR, Milroy JG, Rickards D (1990) Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Br J Urol 66:58–65.
Milroy E, Chapple CR (1993) The Urolume stent in the management of benign prostatic hyperplasia. J Urol 150:1630–1635.
Milroy E, Coulage C, Pansadoro V, et al. (1994) The Urolume permanent prostatic stent as an alternative to TURP: long-term European results. J Urol 151:396A.
Oersterling JE, Fefalco AJ, and the North American Study Group: (1994) The North American experience with the Urolume endoprosthesis as a treatment for benign prostatic hyperplasia: Long term results. Urology 44:353–362.
Guazzoni G, Pansadoro V, Montorsi F, et al. (1994) A modified prostatic Urolume wallsten for healthy patients with symptomatic benign prostatic hyperplasia: A European multicentre study. Urology 44:364–374.
Williams G, Jager R, McLoughlin J, El Din A, Machan L, Gill K, Asopa R, Adam A (1989)Use of stents for treating obstruction of urinary outflow in patients unfit for surgery. Br Med J 298:1429.
Gabellon S, Wisard M, Leisinger HJ (1994) A prospective clinical study of the Urolume endoprosthesis for the treatment of benign prostatic hyperplasia in inoperable patients. J Urol 151:396A.
Guazzoni G, Bergamaschi F, Montorsi F. et al. (1993) Prostatic Urolume wallsten for benign prostatic hyperplasia patients at poor operative risk: Clinical uroflowmetric and ultrasonographic patterns. J Urol 150:1641.
Williams G, Coulange C, Milroy EJG, Sarramon JP, Rubben H (1993) The Urolume, a permanently implanted prostatic stent for patients at high risk of surgery: Results from 5 collabrative centres. Br J Urol 72:335–340.
Holmes SA, Miller PD, Crocker P, et al. (1992) Encrustation of intraprostatic stents—a comparative study. Br J Urol 69:383–387.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chapple, C.R., Damian Png, J.C., Nordling, J., Milroy, E.J.G. (2002). Urolume Stents in the Management of Benign Prostatic Hyperplasia. In: Carson, C.C. (eds) Urologic Prostheses. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-096-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-59259-096-4_7
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-242-1
Online ISBN: 978-1-59259-096-4
eBook Packages: Springer Book Archive